factual

Regulation certifies effectiveness, not comparative value

The FDA and Medicare do not legally evaluate whether a treatment is worth its cost; certification only requires showing a treatment is medically effective, often against a placebo rather than against the next-best existing drug (the opportunity cost), so treatments get approved and covered without any comparison establishing whether they are cost-effective or better than cheaper alternatives.

factualpending

Speaker

Jonathan Skinner

Evidence Quote

“they are not asked to actually compare whether this one is any better... I don't think that the regulatory structure in the United States is set up to make these kinds of comparisons, to say, 'Yes, this is cost effective, and this isn't.'”

Source

Jonathan Skinner on Health Care Costs, Technology, and Rising Mortality— EconTalk
Created: 6/13/2026, 12:21:47 AM

Your notes

Loading notes...